Microarray gene expression profiling reveals potential mechanisms of tumor suppression by the class I HDAC-selective benzoylhydrazide inhibitors. Genomic data, 2015.
Single-Sample, Multiomic Mass Spectrometry for Investigating Drug Effects and Mechanism. Journal of Proteome Research, 2025. (Corresponding author)